Study finds that Sabinsa’s standardized beetroot extract is safe and well tolerated

Photo © AdobeStock.com/liliya

A recent human study¹ found that supplementation with a standardized beetroot extract was safe and well tolerated. In the study, a group of 12 older men and women were randomized to receive either 20 grams of beetroot extract or matching placebo daily for 12 weeks. The researchers observed the safety and tolerability of supplementation as well as changes in anthropometric, biochemical, and hemodynamic parameters. Results showed that no serious adverse events were reported, but anthropometric, biochemical, and hemodynamic parameter changes from baseline were not statistically significant. While plasma nitrate levels did increase significantly in the group taking the beetroot extract, the changes between the groups did not reach statistical significantly. Likewise, participants taking the beetroot extract also saw significantly lower levels of insulin between four and 12 weeks, though there was no significant main effect for time.

“This preliminary study was conducted to underscore the safety and tolerability of Sabeet, but we are pleased to see the benefits it indicated as well,” said Shaheen Majeed, Global CEO and managing director of The Sami-Sabinsa Group, in a press release. “These findings align with our commitment to providing scientifically backed, safe, and effective dietary supplements. Sabinsa extends its gratitude to the team in Food and Nutrition Institute at Federal University of Rio de Janeiro for their collaboration in this study, and we look forward to continuing collaboration.”

Reference

Dos Santos Pinheiro, V.; Junior, O.J.F.R.; Ortmann, C.F.; Pande, A.; Conte-Junior, C.A.; Alvares, T.S. Evaluation of 12-Week Standardized Beetroot Extract Supplementation in Older Participants: A Preliminary Study of Human Health Safety. Nutrients. 2024, 16 (2), 1942. DOI: 10.3390/nu16121942